{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:00:22Z","timestamp":1769842822802,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0184-8","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T08:31:12Z","timestamp":1502872272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-5397","authenticated-orcid":false,"given":"Niklas","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Santacatterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"K\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"H\u00e4gerstrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Mia","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"issue":"8","key":"184_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0104515","volume":"9","author":"NE Palmateer","year":"2014","unstructured":"Palmateer NE, Taylor A, Goldberg DJ, Munro A, Aitken C, Shepherd SJ, et al. Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS One. 2014;9(8):1\u201314.","journal-title":"PLoS One"},{"issue":"2","key":"184_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0087872","volume":"9","author":"JS Montaner","year":"2014","unstructured":"Montaner JS, Lima VD, Harrigan PR, Lourenco L, Yip B, Nosyk B, et al. Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the \"HIV treatment as prevention\" experience in a Canadian setting. PLoS One. 2014;9(2):1\u201310.","journal-title":"PLoS One"},{"key":"184_CR3","unstructured":"ECDC and EMCDDA. Prevention and control of infectious diseases among people who inject drugs. Stockholm: ECDC. 2011:55."},{"issue":"RR-5","key":"184_CR4","first-page":"1","volume":"61","author":"Centers for Disease Control Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. Morbidity and mortality weekly report Recommendations and reports \/ Centers for Disease Control. 2012;61(RR-5):1\u201346.","journal-title":"Morbidity and mortality weekly report Recommendations and reports \/ Centers for Disease Control"},{"issue":"2","key":"184_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2893.2010.01276.x","volume":"18","author":"AS Duberg","year":"2011","unstructured":"Duberg AS, Pettersson H, Aleman S, et al. The burden of hepatitis C in Sweden: a national study of inpatient care. J Viral Hepat. 2011;18(2):106\u201318.","journal-title":"J Viral Hepat"},{"key":"184_CR6","doi-asserted-by":"crossref","unstructured":"Grebely J, et al. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs. Int J Drug Policy. 2017. \nhttp:\/\/dx.doi.org\/10.1016\/j.drugpo.2017.05.019\n\n.","DOI":"10.1016\/j.drugpo.2017.05.019"},{"key":"184_CR7","unstructured":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV\/AIDS surveillance in Europe 2014. Stockholm: ECDC; 2015."},{"key":"184_CR8","volume-title":"Number of new HIV and HCV cases among PWID in Sweden","author":"M Axelsson","year":"2016","unstructured":"Axelsson M. Number of new HIV and HCV cases among PWID in Sweden. In: Karlsson N, editor. Public Health Agency of Sweden; 2016."},{"key":"184_CR9","first-page":"519","volume":"21","author":"A Duberg","year":"2008","unstructured":"Duberg A, Janzon R, Back E, Ekdahl K, Blaxhult A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill. 2008;(21):519\u201340.","journal-title":"Euro Surveill."},{"key":"184_CR10","unstructured":"Tryggvesson K. \u201cSprutbyte \u2013 visst bara de slutar med droger\u201d. Svenska myndigheters och politikers hantering av rena sprutor till narkomaner. Nordic Stud Alcohol Drugs 2012. p. 519."},{"key":"184_CR11","unstructured":"Folkh\u00e4lsomyndigheten. H\u00e4lsofr\u00e4mjande och f\u00f6rebyggande arbete med hepatit och hiv f\u00f6r personer som injicerar droger : en v\u00e4gledning. Solna: Folkh\u00e4lsomyndigheten; 2015. p. 68."},{"issue":"1","key":"184_CR12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.01413-10","volume":"85","author":"H Skar","year":"2011","unstructured":"Skar H, Axelsson M, Berggren I, Thalme A, Gyllensten K, Liitsola K, et al. Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki. Finland J Virol. 2011;85(1):510\u20138.","journal-title":"Finland J Virol"},{"issue":"5","key":"184_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1371\/journal.pmed.1002032","volume":"13","author":"S Iyengar","year":"2016","unstructured":"Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis. PLoS Med. 2016;13(5):44\u201356.","journal-title":"PLoS Med"},{"key":"184_CR14","unstructured":"L\u00e4kemedelsverket. L\u00e4kemedelsbehandling av hepatit C-virusinfektion hos vuxna och barn \u2013 behandlingsrekommendation: Information fr\u00e5n L\u00e4kemedelsverket. L\u00e4kemedelsverket. 2015:45\u20136."},{"issue":"9","key":"184_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/00365540903062143","volume":"41","author":"C Lidman","year":"2009","unstructured":"Lidman C, Norden L, Kaberg M, Kall K, Franck J, Aleman S, et al. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender. Scand J Infect Dis. 2009;41(9):679\u201384.","journal-title":"Scand J Infect Dis"},{"key":"184_CR16","unstructured":"Folkh\u00e4lsomyndigheten. Riskbeteenden, hiv och hepatit bland personer som injicerade droger i Stockholm, 1987\u20131998, En \u00f6versikt baserad p\u00e5 data fr\u00e5n Socialmedicinska H\u00e4ktesprojektet. p. 2014."},{"issue":"1","key":"184_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, et al. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25(1):34\u201352.","journal-title":"Int J Drug Policy."},{"issue":"12","key":"184_CR18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2893.2010.01400.x","volume":"18","author":"MA Blom\u00e9","year":"2011","unstructured":"Blom\u00e9 MA, Bj\u00f6rkman P, Flamholc L, Jacobsson H, Molnegren V, Widell A. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program. J Viral Hep. 2011;18(12):831\u20139.","journal-title":"J Viral Hep"},{"key":"184_CR19","unstructured":"Lag (2006:323) om utbyte av sprutor och kanyler. Stockholm: Socialdepartementet; 2006. p. 2."},{"key":"184_CR20","volume-title":"AUDIT och DUDIT \u2013 Att identifiera problem med alkohol och droger","author":"A Berman","year":"2012","unstructured":"Berman A, Wennberg P, K\u00e4llmen H. AUDIT och DUDIT \u2013 Att identifiera problem med alkohol och droger. Stockholm: Gothia; 2012."},{"issue":"3","key":"184_CR21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2010.04.020","volume":"111","author":"L Lundholm","year":"2010","unstructured":"Lundholm L, Kall K, Wallin S, Thiblin I. Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug Alcohol Depend. 2010;111(3):222\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"184_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/heapro\/15.1.87","volume":"15","author":"J Dixon","year":"2000","unstructured":"Dixon J. Social determinants of health. Health Promot Int. 2000;15(1):87\u20139.","journal-title":"Health Promot Int"},{"key":"184_CR23","unstructured":"The Swedish National Agency for Education. The Swedish Education System Sweden: The Swedish National Agency for Education; [updated 2017\u201301-13; cited 2017 01 February]. Available from: \nhttp:\/\/www.skolverket.se\/om-skolverket\/andra-sprak\/in-english\/the-swedish-education-system\n\n."},{"issue":"3","key":"184_CR24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1081\/ADA-120006736","volume":"28","author":"SB Montgomery","year":"2002","unstructured":"Montgomery SB, Hyde J, De Rosa CJ, Rohrbach LA, Ennett S, Harvey SM, et al. Gender differences in hiv risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28(3):453\u201375.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"184_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jurban\/jtg137","volume":"80","author":"J Evans","year":"2003","unstructured":"Evans J, Hahn J, Page-Shafer K, Lum P, Stein E, Davidson P, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO study). J Urban Health. 2003;80(1):137\u201346.","journal-title":"J Urban Health."},{"issue":"14","key":"184_CR26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1081\/JA-100108439","volume":"36","author":"SG Sherman","year":"2001","unstructured":"Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36(14):2113\u201336.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"184_CR27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijid.2005.07.010","volume":"10","author":"S Parviz","year":"2006","unstructured":"Parviz S, Fatmi Z, Altaf A, McCormick JB, Fischer-Hoch S, Rahbar M, et al. Background demographics and risk behaviors of injecting drug users in Karachi. Pakistan Int J Infect Dis. 2006;10(5):364\u201371.","journal-title":"Pakistan Int J Infect Dis"},{"issue":"Suppl 1","key":"184_CR28","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0376-8716(06)80009-8","volume":"82","author":"RE Booth","year":"2006","unstructured":"Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, Brewster JT, Salomonsen-Sautel S, Corsi KF, et al. Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend. 2006;82(Suppl 1):S49\u201355.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"184_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-10-23","volume":"10","author":"W Chen","year":"2013","unstructured":"Chen W, Xia Y, Hong Y, Hall BJ, Ling L. Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China\u2014a prospective study. Harm Reduct J. 2013;10(1):23.","journal-title":"Harm Reduct J."},{"key":"184_CR30","unstructured":"\u00d6kad tillg\u00e4nglighet till sprututbytesverksamheter i Sverige - Socialutskottets bet\u00e4nkande 2016\/17:SoU4, (2017)."},{"key":"184_CR31","doi-asserted-by":"crossref","unstructured":"Norden L, Saxon L, Kaberg M, Kall K, Franck J, Lidman C. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden. Scand J Infect Dis 2009;41(10):727-734.","DOI":"10.1080\/00365540903159279"},{"issue":"2","key":"184_CR32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugpo.2012.08.003","volume":"24","author":"S Vorobjov","year":"2013","unstructured":"Vorobjov S, Des Jarlais DC, Abel-Ollo K, Talu A, R\u00fc\u00fctel K, Uusk\u00fcla A. Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys. Int J Drug Policy. 2013;24(2):150\u20135.","journal-title":"Int J Drug Policy."},{"issue":"2","key":"184_CR33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1475-682X.2006.00154.x","volume":"76","author":"MW Boeri","year":"2006","unstructured":"Boeri MW, Sterk CE, Elifson KW. Baby boomer drug users: career phases, social control, and social learning theory*. Socio Inq. 2006;76(2):264\u201391.","journal-title":"Socio Inq"},{"issue":"4","key":"184_CR34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s11524-011-9571-8","volume":"88","author":"I Chikovani","year":"2011","unstructured":"Chikovani I, Bozicevic I, Goguadze K, Rukhadze N, Gotsadze G. Unsafe injection and sexual risk behavior among injecting drug users in Georgia. J Urban Health. 2011;88(4):736\u201348.","journal-title":"J Urban Health"},{"issue":"1","key":"184_CR35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7517-7-2","volume":"7","author":"C Strike","year":"2010","unstructured":"Strike C, Buchman D, Callaghan R, Wender C, Anstice S, Lester B, et al. Giving away used injection equipment: missed prevention message? Harm Reduct J. 2010;7(1):2.","journal-title":"Harm Reduct J."},{"issue":"1","key":"184_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jvh.12117","volume":"21","author":"N Palmateer","year":"2014","unstructured":"Palmateer N, Hutchinson S, McAllister G, Munro A, Cameron S, Goldberg D, et al. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat. 2014;21(1):25\u201332.","journal-title":"J Viral Hepat"},{"issue":"3","key":"184_CR37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","volume":"5","author":"AR Bazazi","year":"2011","unstructured":"Bazazi AR, Yokell M, Fu JJ, Rich JD, Zaller ND. Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users. J Addict Med. 2011;5(3):175\u201380.","journal-title":"J Addict Med"},{"issue":"9737","key":"184_CR38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268\u201384.","journal-title":"Lancet"},{"issue":"10","key":"184_CR39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1360-0443.2008.02306.x","volume":"103","author":"T Rhodes","year":"2008","unstructured":"Rhodes T, Treloar C. The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction. 2008;103(10):1593\u2013603.","journal-title":"Addiction"},{"issue":"4","key":"184_CR40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1521\/aeap.2007.19.4.298","volume":"19","author":"MA Davey-Rothwell","year":"2007","unstructured":"Davey-Rothwell MA, Latkin CA. HIV-related communication and perceived norms: an analysis of the connection among injection drug users. AIDS Educ Prev. 2007;19(4):298\u2013309.","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"184_CR41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2009.08.003","volume":"21","author":"A Kr\u00fcsi","year":"2010","unstructured":"Kr\u00fcsi A, Wood E, Montaner J, Kerr T. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21(1):4\u20139.","journal-title":"Int J Drug Policy"},{"key":"184_CR42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7517-10-7","volume":"10","author":"M Harris","year":"2013","unstructured":"Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J. 2013;10:7.","journal-title":"Harm Reduct J"},{"issue":"Suppl 6","key":"184_CR43","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1471-2334-14-S6-S17","volume":"14","author":"A Arain","year":"2014","unstructured":"Arain A, Robaeys G, Stover H. Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infect Dis. 2014;14(Suppl 6):S17.","journal-title":"BMC Infect Dis"},{"key":"184_CR44","unstructured":"Utbyte av sprutor och kanyler till personer som missbrukar narkotika SOFS 2007:2, SOFS 2007:2 (2007)."},{"key":"184_CR45","unstructured":"Socialdepartementet. Regeringens proposition 2005\/06:60 Nationell strategi mot hiv\/aids och vissa andra smittsamma sjukdomar. Stockholm: 2005. p. 1-211."},{"issue":"25","key":"184_CR46","first-page":"1221","volume":"109","author":"K Hillgren","year":"2012","unstructured":"Hillgren K, Sarkar K, Elofsson S, Britton S. Widespread risk behavior among injecting drug users. Over 80 percent HCV-infected\u20147 percent have HIV, as demonstrated by the first baseline study. Lakartidningen. 2012;109(25):1221\u20135.","journal-title":"Lakartidningen"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T08:31:40Z","timestamp":1502872300000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0184-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]},"article-number":"57"}}